title: Inhibitory effects of recombinant human interleukin 10 on disease manifestations in a P-->F1 model of acute graft versus host disease.
abstract: Interleukin 10 (IL-10) is a cytokine with both antiinflammatory and immunosuppressive properties. In the present study, we have examined the effects of recombinant human IL-10 (rHuIL-10) on the development of acute graft-vs.-host disease (GVHD) in unirradiated (C57B1/6JxA/J) F1 recipients of parental A/J lymphocytes. rHuIL-10 (2.5 to 100 micrograms/mouse administered subcutaneously) caused a significant reduction in splenomegaly in GVH mice. GVH splenocytes exhibited an augmented capacity to produce IFN-gamma when stimulated in culture with Con A or LPS. The IFN gamma produced in response to LPS stimulation was found to be derived from CD4+ and CD8+ T cells with little or no contribution from the NK1.1+ subpopulation of the GVH spleen. Treatment with IL-10 in vivo was found to diminish the capacity of splenocytes to produce IFN gamma when stimulated with LPS but not with Con A. IL-10 did not protect GVH mice from a lethal dose of LPS but caused a marked reduction in the serum TNF alpha response triggered by the LPS challenge. We conclude that IL-10 may be useful in controlling those clinical manifestations of acute GVHD that arise as a result of the activities of proinflammatory cytokines such as IFN gamma and TNF alpha.
authors.affiliation: Department of Immunology, Schering-Plough Research Institute, Kenilworth, NJ 07033, USA.
authors.forename: S R
authors.initials: SR
authors.lastname: Smith
authors.forename: C
authors.initials: C
authors.lastname: Terminelli
authors.forename: K J
authors.initials: KJ
authors.lastname: Pennline
authors.forename: L
authors.initials: L
authors.lastname: Kenworthy-Bott
authors.forename: J
authors.initials: J
authors.lastname: Donkin
authors.forename: A
authors.initials: A
authors.lastname: Calzetta
mesh_terms: D000818:Animals; D017690:Cell Transplantation; D002478:Cells, Cultured; D004195:Disease Models, Animal; D006086:Graft vs Host Disease / Q000188:drug therapy*; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis; D016753:Interleukin-10 / Q000008:administration & dosage*; D008214:Lymphocytes / Q000276:immunology / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D011994:Recombinant Proteins / Q000008:administration & dosage; D013154:Spleen / Q000473:pathology; D013163:Splenomegaly / Q000517:prevention & control*
chemical_list: D011994:Recombinant Proteins; D016753:Interleukin-10; D007371:Interferon-gamma